At a glance
- Originator Bristol-Myers Squibb
- Class Antihypertensives; Sulfonamides; Vasodilators
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary disorders; Hypertension
Most Recent Events
- 17 Feb 2006 Discontinued - Preclinical for Coronary disorders in USA (PO)
- 17 Feb 2006 Discontinued - Preclinical for Hypertension in USA (PO)
- 13 Mar 2002 A study has been added to the Hypertension pharmacodynamics section